Skip to content
Home/Companies/Biotech/EryDel
ER

EryDel

Biotech·Italy·Exited 2023·Held 15yr

EryDel is a biotech company, headquartered in Italy.

Entry
2008
Hold
15yr
Exit
2023
Est. EV
–

Who owns EryDel?

EryDel was owned by Innogest SGR through Innogest Capital I (2007 vintage) from 2008 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-23

Innogest SGR
Investor
Innogest SGR
Innogest Capital I · 2007 · VC

Key facts

HQItaly
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from Innogest Capital I

Other portfolio companies in the same fund.

Digital Magics
Active
Business ServicesItaly· 2016
Drexcode
Active
E-commerceItaly· 2014
Atricath
Active
MedTechItaly· 2013
40South Energy
Active
ClimateTechItaly· 2012
Agroils
Active
AgTechItaly· 2012
Beintoo
Exited 2020
AdTechItaly· 2012
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings